Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

190
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 60125 23525 885
Operating income (EBITDA)9 4158 8838 0457 7247 9428 433
Operating profit (EBIT)8 3308 0156 5946 0846 5016 829
Pre-Tax Profit (EBT)6 6926 6472 9684 4394 7244 710
Net income4 5655 6282 7563 4223 4203 324
EPS (PNC)91,511156,779,172,480,3
Dividend per Share (PNC)74,078,080,080,980,680,9
Yield4,77%5,03%5,16%5,22%5,20%5,22%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37713 16912 60113 477
Finance------
Operating income (EBITDA)9 4158 8838 0457 7247 9428 433
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,70x1,59x1,60x
Capital Expenditure1 0511 1881 1882 2621 4661 618
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC115 PNC68,2 PNC63,6 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC104 PNC207 PNC339 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 75 454 M GBP -
Entreprise Value (EV) 88 622 M GBP 88 055 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 19,6x 21,4x
Capitalization / Revenue 3,07x 2,99x
EV / Revenue 3,60x 3,49x
EV / EBITDA 11,5x 11,1x
Yield (DPS / Price) 5,22% 5,20%
Price to book (Price / BVPS) 13,5x 22,7x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 24,7% 25,8%
operating Leverage (Delta EBIT / Delta Sales) - 2,66x
Net Margin (Net Profit / Revenue) 13,9% 13,6%
ROA (Net Profit / Asset) 7,23% 8,73%
ROE (Net Profit / Equities) 70,0% 87,1%
Rate of Dividend 102% 111%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   9,19% 5,81%
Cash Flow / Sales (Taux d'autofinancement) 20,5% 39,9%
Capital Intensity (Assets / Sales) 1,92x 1,55x
Financial Leverage (Net Debt / EBITDA) 1,70x 1,59x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF